Showing posts with label Trisomy. Show all posts
Showing posts with label Trisomy. Show all posts

Monday, May 25, 2020

NON INVASIVE PRENATAL TESTING (NIPT) MARKET GLOBAL OPPORTUNITY ANALYSIS AND INDUSTRY FORECAST (2019 – 2027)

Meticulous Research®– leading global market research company published a research report titled “Non Invasive Prenatal Testing (NIPT) Market by Product & Solution (Consumables, Systems, Software), Method (Ultrasound Screening, Cell Free DNA Test), Application (Trisomy, Microdeletions, Monosomy), and End-user (Diagnostic Labs) – Global Forecast to 2027”. 
The high growth of non-invasive prenatal testing market is mainly attributed to the high risk of chromosomal abnormalities with increasing maternal age, rise in occurrences of chromosomal aneuploidies among fetus, development of advanced and new technologies and non-invasive parenteral testing products, and improving reimbursement scenario for NIPT. In addition, rising awareness regarding non-invasive prenatal testing and untapped market opportunity in emerging markets offer significant growth opportunities for the players operating in this market.
Non-Invasive Prenatal Testing (NIPT), a novel genetic screening method based on the analysis of cell-free deoxyribose nucleic acid (cf-DNA) of the fetus in the maternal plasma is considered as a valuable test for the pregnant women to provide early diagnosis of genetic disorders. NIPT offers several advantages over conventional prenatal testing procedures; in addition to being non-invasive, these tests offer shorter turnaround times, lower risk to fetus and pregnant women during testing, and high accuracy. Increasing occurrences of chromosomal aneuploidies among fetus with the increase in maternal age, availability of the partial reimbursement policies for NIPT services in some of the countries, and developments in new technologies are the key factors driving steady growth in the global NIPT market.
Request Free Sample Report to get the short-term and long-term impact of COVID-19 on this Market https://www.meticulousresearch.com/request-sample-report/cp_id=5068
PNG-Non-Invasive-Prenatal-Testing-(NIPT)-Market---1
The global non-invasive prenatal testing market study presents historical market data in terms of values (2017 and 2018), estimated current data (2019), and forecasts for 2027- by product & solution (consumables, systems, software), method (ultrasound screening, cell free DNA test), application (trisomy, microdeletions, monosomy), and end-user. The study also evaluates industry competitors and analyzes the market at regional and country level.
Click here to get the short-term and long-term impact of COVID-19 on this Market. https://www.meticulousresearch.com/enquire-before-buying/cp_id=5068
On the basis of products and solutions, the kits/consumables segment commanded the largest share of the overall NIPT market in 2019, mainly due to increasing incidences of chromosomal abnormalities, rise in the number of tests and products for NIPT, and improvement of approvals or licenses for assays.
On the basis of application, trisomy segment accounted for the largest share of the overall NIPT market in 2019. The large share of this segment is mainly attributed to the factors such as the increasing maternal age and rising incidence of chromosomal abnormalities.
On the basis of end user, diagnostic laboratories segment accounted for the largest share of the overall NIPT market in 2019, as the large volume of NIPT testing done at diagnostic laboratories owing to availability of the well-equipped facility and availability of trained/skilled laboratory technicians. The initiatives taken by diagnostic laboratories to provide high quality testing services is further driving the growth in this market.
This research report analyzes major geographies and provides comprehensive analysis for North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, and RoAPAC), Latin America, and the Middle East & Africa. North America commanded the largest share of the global non-invasive prenatal testing market in 2019, followed by Europe and Asia-Pacific regions. High diagnostic and treatment rate of trisomy disorders and the emergence of key organizations in the U.S. are accelerating the non-invasive prenatal testing market in the North American region.
Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5068
Key questions answered in the report-
  • Which are the high growth market segments in terms of product & solutions, method, application, end-users, and region/countries?
  • What was the historical market for non-invasive prenatal testing across the globe?
  • What are the market forecasts and estimates for the period 2019-2027?
  • What are the major drivers, restraints, opportunities, and trends in the global non-invasive prenatal testing market?
  • Who are the major players in the non-invasive prenatal testing market?
  • How is the competitive landscape and who are the market leaders in the global non-invasive prenatal testing market?
  • What are the different strategies adopted by the major players in the global non-invasive prenatal testing market?
  • What are the geographical trends and high growth regions/ countries?
Key Players
The key players operating in the global non-invasive prenatal testing market are Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), PerkinElmer, Inc. (Massachusetts), Illumina, Inc. (U.S.), Beijing Genomics Institute (China), Eurofins LifeCodexx AG (Germany), NATERA, INC. (U.S.), Igenomix SL (Spain), Laboratory Corporation of America Holdings (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), GE Healthcare (U.S.), and Yourgene Health (U.K.) among others.
Request Free Sample Report to get the short-term and long-term impact of COVID-19 on this Market https://www.meticulousresearch.com/request-sample-report/cp_id=5068
Scope of the Report:
Non-Invasive Prenatal Testing Market by Product & Solutions
  • Kits / Consumables
  • Systems
    • Nuchal Translucency Ultrasound Devices
    • Next Generation Sequencing Systems
    • Microarrays
    • Polymerase Chain Reaction Instruments
  • Software
Market by Non-Invasive Prenatal Testing Method
  • Ultrasound Screening
  • Cell-free DNA Screening
Non-Invasive Prenatal Testing Market by Application
  • Trisomy Detection
  • Microdeletions Syndrome
  • Sex Chromosomal Abnormalities
  • Other Applications
Note: Other applications include sex determination and cystic fibrosis
Non-Invasive Prenatal Testing Market by End User
  • Diagnostic Laboratories
  • Hospitals
  • Academic and Research Institutes
Non-Invasive Prenatal Testing Market by Geography
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East and Africa                       ………..Continue
Download Sample Copy of Report, published in Feb 2020, with key industry insights spread across 191 pages, with 169 market data tables, 44 fig, including all graphs and charts @:  https://www.meticulousresearch.com/download-sample-report/cp_id=5068
Browse More Report of This Category at:
Urinalysis Market by Product (Pregnancy & Fertility Test, Dipstick, Reagent, Automatic, Semi-automatic, POC Analyzer), Application (Pregnancy, Diabetes, Kidney Disease, UTI), End-user (Hospitals and Clinics, Laboratory, Home Care) – Global Forecast to 2027
Healthcare IT Market by Product (EMR, mHealth, PHM, RIS, PACS, RCM, Healthcare Analytics, Telehealth, SCM, HIE), Component (Software, Service), Delivery Mode (Web, Cloud) and End User (Hospital, Payer, Pharmacy, Ambulatory, Homecare) – Global Forecast to 2027
Healthcare Virtual Assistants Market by Product (Chatbot and Smart Speaker), Technology (Speech Recognition, Text-to-Speech, and Text Based), End User (Providers, Payers, and Other End User), and Geography–Global Forecast to 2025
Digital Diabetes Market by Product (SMBG, CGM, Smart Insulin Pump, Smart Insulin Pens, Software, Apps), End User (Home Care, Hospitals and Clinics), and Geography–Global Forecast to 2025
Contact Us:
Khushal
Meticulous Research®
Contact Sales- +1-646-781-8004
Email: sales@meticulousresearch.com
Website: https://www.meticulousresearch.com
Find us on: | LinkedIn | Twitter |

Monday, January 6, 2020

𝐍𝐨𝐧 𝐈𝐧𝐯𝐚𝐬𝐢𝐯𝐞 𝐏𝐫𝐞𝐧𝐚𝐭𝐚𝐥 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 (𝐍𝐈𝐏𝐓) 𝐌𝐚𝐫𝐤𝐞𝐭 𝟐𝟎𝟏𝟗-𝟐𝟎𝟐𝟕: 𝐌𝐚𝐫𝐤𝐞𝐭 𝐛𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭, 𝐌𝐞𝐭𝐡𝐨𝐝, 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧, 𝐚𝐧𝐝 𝐭𝐨𝐩 𝐤𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬

Meticulous Research®– leading global market research company published a research report titled “Non Invasive Prenatal Testing (NIPT) Market by Product (Consumables, NGS, Ultrasound, Microarray, PCR), Method (Ultrasound Screening, Cell Free DNA Test), Application (Trisomy, Sex Chromosome Abnormalities), & End User – Forecast to 2027”. 
According to this latest publication from Meticulous Research®, the Global Non-Invasive Prenatal Testing Market is expected to grow at a CAGR of 17.1% from 2019 to exceed $13.6 billion by 2027. The high growth of non-invasive prenatal testing market is mainly attributed to the high risk of chromosomal abnormalities with increasing maternal age, rise in occurrences of chromosomal aneuploidies among fetus, development of advanced and new technologies and non-invasive parenteral testing products, and improving reimbursement scenario for NIPT. Rising awareness regarding non-invasive prenatal testing and untapped market opportunity in emerging markets offer significant growth opportunities for the players operating in this market. However, strict regulatory guidelines and ethical hurdles are some of the key factors challenging the adoption of non-invasive prenatal testing products over the coming years.
Table of content
1.Introduction  
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency and Limitations
1.3.1. Currency
1.3.2. Limitations
1.4. Key Stakeholders
2.Research Methodology    
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation
3. Executive Summary    
4. Market Insights
4.1. Introduction
4.2. Drivers     
4.2.1. Increase in Progressive Maternal Age
4.2.2. Rise in Occurrences of Chromosomal Aneuploidies Among Foetus
4.2.3. Availability of Reimbursement Scenario for NIPT
4.2.4. Development of Advanced and New Technologies and Non-Invasive Parenteral Testing Products
4.3. Restraint
4.3.1. High Cost of the Non-invasive Prenatal Screening Techniques
4.4. Opportunities     
4.4.1. Rising Awareness Regarding NIPT
4.4.2. Untapped Emergence of New Market
4.5. Challenges
4.5.1. Reliability of the Tests
5. Global NIPT Market, by Product and Solution
5.1. Introduction
5.2. Consumables
5.3. Systems
5.3.1. Nuchal Translucency Ultrasound Devices
5.3.2. Next-Generation Sequencing Systems
5.3.3. Microarrays
5.3.4. Polymerase Chain Reaction Instruments
5.4. Software
5.5. Services
6. Global NIPT Market, by Method
6.1. Introduction
6.2. Ultrasound Screening
6.3. Cell-Free DNA Screening    …………Continue
Growth prospects in NIPT market
The global non-invasive prenatal testing market study presents historical market data in terms of values (2017 and 2018), estimated current data (2019), and forecasts for 2027-by product and solutions (consumables, instruments, software, services), method (ultrasound detection, biochemical screening tests, cellfree DNA in maternal plasma tests), application (trisomy, microdeletion syndrome, others), and end users. The study also evaluates industry competitors and analyzes the market at a regional and country level.
On the basis of products and solutions, the NIPT services segment is expected to grow at the fastest CAGR during the forecast period. The highest CAGR of this segment is mainly attributed to factors such as rising incidence of genetic disorders, increasing focus on prenatal screening, and government initiatives to provide prenatal testing services.
On the basis of application, trisomy segment is estimated to account for the largest share of the overall NIPT market in 2019. The large share of this segment is mainly attributed to the factors such as increasing maternal age and rising incidence of chromosomal abnormalities.
On the basis of end user, diagnostic laboratories segment is estimated to account for the largest share of the overall NIPT market in 2019, due to large volume of NIPT testing done at diagnostic laboratories owing to availability of the well-equipped facility and trained/skilled laboratory technicians. The initiatives taken by diagnostic laboratories to provide high quality testing services is driving the growth in this market.
Download sample copy of report before purchasing this report @  https://www.meticulousresearch.com/request-sample-report/cp_id=5068
This research report analyzes major geographies and provides comprehensive analysis for North America (U.S., Canada), Europe (Germany, France, the U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, and RoAPAC), Latin America, and Middle East & Africa. North America commanded the largest share of the global non-invasive prenatal testing market, followed by Europe and Asia-Pacific. High diagnostic and treatment rate of trisomy disorders and the emergence of key organizations in the U.S. are accelerating the non-invasive prenatal testing market in the North American region. However, Asia Pacific region is expected to grow at the highest CAGR during the forecast period due to developing healthcare infrastructure, rising focus of prominent players on expanding their presence in Asia, and rising awareness programs & conferences.
The key players operating in the global non-invasive prenatal testing market are Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), PerkinElmer, Inc. (U.S.), Illumina, Inc. (U.S.), Beijing Genomics Institute (China), Eurofins LifeCodexx AG (Germany), NATERA, INC. (U.S.), Igenomix SL (Spain), Laboratory Corporation of America Holdings (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), GE Healthcare (U.S.), and Yourgene Health (U.K.) among others.
Key questions answered in the report-
  • Which are the high growth market segments in terms of product & solutions, method, application, end-users, and region/countries?
  • What was the historical market for non-invasive prenatal testing across the globe?
  • What are the market forecasts and estimates for the period 2019-2027?
  • What are the major drivers, restraints, opportunities, and trends in the global non-invasive prenatal testing market?
  • Who are the major players in the non-invasive prenatal testing market?
  • How is the competitive landscape and who are the market leaders in the global non-invasive prenatal testing market?
  • What are the different strategies adopted by the major players in the global non-invasive prenatal testing market?
  • What are the geographical trends and high growth regions/ countries?
Contact Us:
Meticulous Research®
Contact Sales- +1-646-781-8004